
koto_feja/E+ via Getty Images
KalVista Pharmaceuticals (NASDAQ:KALV), Biogen (NASDAQ:BIIB), and Ionis Pharmaceuticals (NASDAQ:IONS) announced that the European Medicines Agency (EMA) has given positive endorsements for their products.
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for KalVista's Sebetralstat, an oral medication